UP - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • Peak left atrial longitudin...
    Gomes, Daniel A; Lopes, Pedro M; Freitas, Pedro; Albuquerque, Francisco; Reis, Carla; Guerreiro, Sara; Abecasis, João; Trabulo, Marisa; Ferreira, António M; Ferreira, Jorge; Ribeiras, Regina; Mendes, Miguel; Andrade, Maria J

    Cardiovascular ultrasound, 05/2023, Letnik: 21, Številka: 1
    Journal Article

    Chronic mitral regurgitation promotes left atrial (LA) remodeling. However, the significance of LA dysfunction in the setting of ventricular functional mitral regurgitation (FMR) has not been fully investigated. Our aim was to assess the prognostic impact of peak atrial longitudinal strain (PALS), a surrogate of LA function, in patients with FMR and reduced left ventricular ejection fraction (LVEF). Patients with at least mild ventricular FMR and LVEF < 50% under optimized medical therapy who underwent transthoracic echocardiography at a single center were retrospectively identified in the laboratory database. PALS was assessed by 2D speckle tracking in the apical 4-chamber view and the study population was divided in two groups according to the best cut-off value of PALS, using receiver operating characteristics (ROC) curve analysis. The primary endpoint-point was all-cause mortality. A total of 307 patients (median age 70 years, 77% male) were included. Median LVEF was 35% (IQR: 27 - 40%) and median effective regurgitant orifice area (EROA) was 15mm (IQR: 9 - 22mm ). According to current European guidelines, 32 patients had severe FMR (10%). During a median follow-up of 3.5 years (IQR 1.4 - 6.6), 148 patients died. The unadjusted mortality incidence per 100 persons-years increased with progressively lower values of PALS. On multivariable analysis, PALS remained independently associated with all-cause mortality (adjusted hazard ratio 1.052 per % decrease; 95% CI: 1.010 - 1.095; P = 0.016), even after adjustment for several (n = 14) clinical and echocardiographic confounders. PALS is independently associated with all-cause mortality in patients with reduced LVEF and ventricular FMR.